BPCBPC-157
01 TRENDING TOPICS
02 RESEARCH FEED
Access without approval: state-level determinants of peptide availability in sexual medicine.
BackgroundDespite increasing use of peptides in sexual medicine, interstate differences in access are not fully explained by federal approval status and may instead reflect variation in state-level healthcare delivery…
Sexual medicine · 2026Peptides for Targeting Chondrogenic Induction and Cartilage Regeneration in Osteoarthritis.
ObjectsOsteoarthritis (OA) is a widespread degenerative joint condition commonly occurring in older adults. Currently, no disease-modifying drugs are available, and safety concerns associated with commonly used…
Cartilage · 2026Efficient Expression of Small Molecule Bioactive Peptides in Bacillus licheniformis.
Stable expression of γ-Glutamyltranspeptidase (GGT)-BPC157 and mScarlet-BPC157 in Bacillus licheniformis strain 2709 by chromosomal integration. Fermentation conditions were optimized using single-factor and orthogonal…
Applied biochemistry and biotechnology · 2026Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.
Purpose of reviewThis narrative review summarizes the current evidence on regenerative peptides relevant to chronic pain management, including collagen peptides, body protection compound-157 (BPC-157), thymosin beta-4…
Current pain and headache reports · 2026Peptide Supplements and Their Therapeutic Applications in Sports Medicine.
BackgroundThe peptide supplement market has experienced rapid growth due to marketing claims of enhanced performance and accelerated recovery from musculoskeletal injury. These peptides are increasingly popular with…
The American journal of sports medicine · 2026Fabrication and characterization of biocompatible BPC-157 based chitosan hydrogel.
Multifunctional hydrogels are essential for advanced biomedical applications. In this study, CH/BPC composite hydrogel was fabricated and characterized for their physicochemical properties. The formulation exhibited a…
3 Biotech · 2026Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated…
Sports medicine (Auckland, N.Z.) · 2026Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.
ObjectivesThis study aims to evaluate the effects of BPC-157, synthetic thymosin beta-4 (TB-500), and their combination on Achilles tendon healing using biomechanical, histopathological, histochemical, and…
Joint diseases and related surgery · 2026Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review.
Supplementation use in athletes is common and increasing in popularity, especially for adults seeking improvements in athletic performance. However, the effects of supplementation for older adults or Masters athletes in…
Current sports medicine reports · 2026Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices.
Recently, methods for detecting small peptides in dried blood spots have been published. These procedures typically involve multiple sample preparation steps, resulting in labor-intensive and costly workflows. In the…
The Analyst · 2026Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats.
In rats, stable gastric pentadecapeptide (BPC 157) therapy may resolve severe gentamicin nephrotoxicity (100 mg/kg ip/daily through 8 days) and the nitric oxide (NO)-system relation. We applied BPC 157 (10 µg/kg, 10…
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2026Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks.
Unregulated peptide use is emerging as a digitally mediated public health concern. Although peptide-based medicines have important therapeutic roles when developed, prescribed, manufactured, and monitored through…
Cureus · 2026Therapeutic peptides and proteins: Status and developments in drug delivery.
Peptides and proteins are the most dynamic class of biomolecules, performing a diverse range of physiological functions including biochemical catalysis, ion transport, molecular signaling, and genetic/epigenetic…
Journal of controlled release : official journal of the Controlled Release Society · 2026Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach.
Background. This rat study reveals a new point: the considerable impact of unilateral adrenalectomy, severe vascular and multiorgan failure, occlusion/occlusion-like syndrome, and the stable gastric pentadecapeptide BPC…
Pharmaceuticals (Basel, Switzerland) · 2026BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase.
Acetylcholinesterase (AChE) inhibition remains a key therapeutic strategy in the management of neurodegenerative disorders such as Alzheimer's disease. In this study, the inhibitory potential of the gastric…
International journal of molecular sciences · 2026Current State of Orthobiologics in Treatment of Knee Osteoarthritis-Future Directions.
As the population ages, the incidence and prevalence of musculoskeletal degeneration, such as osteoarthritis, increase. While the currently accepted treatment options provide symptomatic and functional improvement, they…
International journal of molecular sciences · 2026Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury.
Ischemia-reperfusion (I/R) injury remains a major complication in peripheral arterial disease, characterized by oxidative stress, inflammation, and apoptosis. Body Protection Compound-157 (BPC 157), a stable gastric…
Scientific reports · 2026BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers.
Background/Objectives: BPC-157 (body protection compound 157) is a synthetic pentadecapeptide derived from a gastric protein fragment with reported cytoprotective and regenerative properties across multiple organ…
Pharmaceutics · 2026Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications.
BackgroundInjectable peptides are increasingly promoted for musculoskeletal recovery, tissue repair, and performance enhancements; however, clinical adoption has outpaced high-quality evidence and regulatory…
JBJS reviews · 2026Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in Human Internal Mammary Artery.
Background/Objectives: Body Protection Compound-157 (BPC 157) is a stable gastric pentadecapeptide with cytoprotective, pro-angiogenic, and nitric oxide (NO)-modulating properties that has gained increasing attention…
Journal of clinical medicine · 2026Myotendinous Junction development and repair.
The myotendinous junction (MTJ) is the critical interface connecting muscle to tendon, enabling force transmission for movement and serving as the primary site of muscle injuries. Despite research into MTJ repair,…
Journal of orthopaedic translation · 2026Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation.
Thyroid disorders, particularly autoimmune conditions such as Hashimoto's thyroiditis, are frequently associated with persistent systemic symptoms despite biochemical normalization with standard hormone replacement,…
Integrative medicine (Encinitas, Calif.) · 2026Regenerative Medicine Approaches to Craniofacial and Corneal Neuropathic Pain.
Craniofacial and corneal neuropathic pain are disabling conditions characterized by persistent pain that is frequently refractory to conventional pharmacologic and interventional therapies. These disorders arise from…
Pharmaceuticals (Basel, Switzerland) · 2026Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.
Therapeutic peptides are short chains of amino acids used to treat metabolic and endocrine conditions such as obesity and type 2 diabetes. While several peptide drugs have undergone rigorous approval processes that…
International journal of molecular sciences · 202603 FACT BANK
A synthetic 15-amino-acid peptide — a "pentadecapeptide" — based on a protective compound found in human gastric juice.
Mostly in animal models: stomach and gut-lining healing, tendon, ligament, muscle and bone repair, and blood-vessel growth.
Linked to angiogenesis, growth-factor signalling and the nitric-oxide system — associated with faster tissue repair in models.
GEPPPGKPADDAGLV — fifteen residues. Marketed as a stable "Body Protection Compound," which is where the BPC name comes from.
Not FDA-approved. Sold as a research chemical; its US compounding status is under active FDA review (PCAC, Jul 2026).
Banned by WADA under S0 (non-approved substances) — prohibited at all times, in and out of competition.